Harvest Technology Group Grants 120 Million Unlisted Options at $0.02 Exercise Price to Lead Manager

Overview of the 120 Million Option Issuance

On 23 July 2026, Harvest Technology Group Ltd formally issued 120 million unlisted options in line with the placement transaction disclosed via an Appendix 3B on 27 May 2026. These options, part of the lead manager remuneration, are not listed on the ASX. Each option carries an exercise price of AUD $0.02 and expires on 23 July 2028, granting the lead manager a two-year period to convert these options into ordinary shares if market conditions are favourable.

Unlike cash payments, issuing unlisted options aligns the lead manager’s interests with HTG’s share price performance. Should the ordinary share price exceed $0.02 before expiry, the options gain economic value and can be converted into equity. This practice is common in Australian capital markets, enabling companies to reduce upfront cash payments during placements while offering potential upside to brokers and lead managers.

Reducing Upfront Costs Through Options-Based Lead Manager Remuneration

HTG structured part of the lead manager’s compensation through 120 million unlisted options instead of cash fees. This strategy conserves the company’s cash during the capital raising phase, which is crucial for growth companies or those managing working capital. By compensating with equity securities, HTG defers economic costs until options are exercised or expire worthless.

This approach indicates HTG’s emphasis on cash preservation during the placement. The lead manager benefits only if HTG’s share price rises above the $0.02 exercise price within two years. If shares stay below $0.02, the options may lapse unexercised, resulting in no economic gain for the lead manager. This arrangement aligns interests, as both parties benefit from share price appreciation post-placement.

Connection to the May 2026 Placement Transaction

The 23 July 2026 option issuance completes the securities component of the placement announced on 27 May 2026. HTG confirmed no further securities remain outstanding to finalize the placement, marking the conclusion of the capital raising activities. The May announcement outlined the placement structure, while the July issuance confirms the execution of lead manager compensation via unlisted options.

HTG stated the options are not intended for ASX quotation and were privately negotiated with the placement lead manager. The two-month interval between the initial announcement and option issuance aligns with typical settlement and documentation timelines in Australian capital markets. The Appendix 3G filing ensures transparency and compliance with ASX Listing Rules regarding capital structure changes.

Exercise Price and Expiry Details of the New Options

The 120 million options have an exercise price of AUD $0.02, making them in-the-money or near-the-money depending on HTG’s share price at exercise. The expiry date of 23 July 2028 provides a two-year window for conversion into ordinary shares. This relatively short expiry period suggests an expectation of share price movement within this timeframe.

The $0.02 strike price is lower than other HTG option series, which have exercise prices ranging from $0.025 to $0.0377 with various expiry dates. This lower price may reflect market conditions at the time of negotiation or confidence in near-term share price growth. Exercised options will convert into fully paid ordinary shares, increasing the share count and potentially triggering disclosure obligations depending on volume and timing.

HTG’s Overall Capital Structure and Outstanding Securities

Following this issuance, HTG has approximately 1.59 billion fully paid ordinary shares on issue. The company’s unquoted securities include multiple option series, performance rights, and convertible notes. Currently, HTG holds 75 million performance rights, about 430 million unquoted options across seven series with exercise prices between $0.02 and $0.0377 and expiries from October 2027 to December 2028, plus 5.5 million convertible notes.

This complex capital structure is typical for growth-stage Australian companies that have conducted multiple capital raises and equity-based incentives. The mix of performance rights, options, and convertible notes indicates HTG’s use of diverse mechanisms to fund operations and align stakeholder interests while conserving cash. The concentration of options expiring in 2027 and 2028 points to potential significant refinancing or capital events ahead. Investors should monitor option exercises and share price movements closely, as these will impact dilution over the next two years.

ASX Compliance and Regulatory Disclosure

HTG’s issuance of 120 million unlisted options complies with ASX Listing Rules on unquoted securities disclosure. The company lodged an Appendix 3G, the required notification for unquoted securities not intended for ASX quotation. HTG confirmed ASX approval of the option terms under Listing Rule 6.1, ensuring fairness among security holders.

All material terms—including exercise price, expiry, and conversion conditions—are documented and accessible via the ASX notification. This transparency supports investor review and maintains corporate governance standards. HTG’s adherence to disclosure obligations reflects ASX’s regulatory oversight of capital structure changes.

Potential Dilution Impact from Option Exercise

If all 120 million options are exercised at $0.02 before 23 July 2028, HTG’s ordinary shares would increase from approximately 1.59 billion to 1.71 billion, representing about 7.6% dilution on a fully diluted basis. Dilution only materializes if the share price exceeds $0.02 sufficiently to incentivize exercise. Otherwise, options may expire worthless, causing no dilution.

Considering HTG’s other 430 million unquoted options with higher exercise prices, a strong share price rally could lead to multiple option series being exercised simultaneously, causing significant aggregate dilution. Conversely, a weak share price environment may result in most options lapsing. Investors should watch share price trends and option exercise timing, as these factors will influence earnings per share and ownership percentages through 2027–2028.

Investor Considerations on HTG’s Capital Management

The May 2026 placement completion and lead manager option issuance indicate HTG has finalized its immediate capital raising. However, the large portfolio of unquoted securities—including performance rights vesting soon and convertible notes—suggests further capital management events are likely within 12 to 24 months. Investors should monitor announcements regarding performance right vestings and convertible note refinancing or conversions.

The lead manager option grant also signals successful placement execution and acceptance of equity-based compensation terms. Investors may seek details on placement size, pricing, and proceeds use from earlier disclosures or upcoming financial reports. Completing this securities milestone allows management to focus on deploying capital and advancing company goals that could drive share price gains, enhancing the attractiveness of the $0.02 exercise price for option conversion.

Comparison of Lead Manager Options to Existing Series

The 120 million options issued on 23 July 2026 represent the largest single option issuance in HTG’s current capital structure. Existing unquoted options vary in exercise prices and expiry dates, such as 81.6 million options expiring 20 April 2028 at $0.025 and 58.9 million expiring 26 April 2027 at $0.03—both higher strike prices and earlier expiries than the lead manager options. These differences reflect issuance timing and market conditions.

The lead manager’s $0.02 exercise price is among the lowest in HTG’s unquoted portfolio, likely reflecting placement negotiation timing or competitive broker market dynamics. The two-year expiry is shorter than some longer-dated employee options. Overall, HTG’s unquoted securities demonstrate a flexible capital management approach that balances cash conservation with aligning interests of management, service providers, and shareholders through equity incentives tied to share price appreciation.